Intermittent pneumatic compression therapy improves functional and dynamic balance and neuropathy severity in neuropathic patients with type 2 diabetes

  • Shirin Salek
  • Farid Bahrpeyma
  • Mohammad-Reza Mohajeri-Tehrani
Original Article
  • 100 Downloads

Abstract

Diabetic neuropathy is a common complication of diabetes which increases risk of falling. Reduction in neural blood flow is one proposed theory for this etiology of diabetic neuropathy. Intermittent pneumatic compression (IPC) is a treatment method that increases nutritional supplies for the peripheral nervous system. The current study aims at evaluating the effects of IPC therapy on two aspects of balance dysfunction as one of the most important clinical signs of diabetic neuropathy. This study is a single-blind, randomized, controlled clinical trial that involved 39 patients with diabetic peripheral neuropathy. In this analysis, patients aged 40–75 years (with a mean age of 58.82 years) were randomly divided into intervention (n = 20) and control groups (n = 19). In the first session, all tests of neuropathy severity (using Valk and Michigan diabetic neuropathy questionnaires) and stability (functional and dynamic balance) were performed for both groups. The subjects in intervention group underwent 10 sessions of IPC treatment. At last, balance and neuropathy examinations were carried out in the final session. P < 0.05 was chosen as statistical significance level. Implementation of IPC interventions for 10 sessions significantly decreased APSI and OSI of Biodex balance system in level 6 (P < 0.05). The subjects in intervention group showed significant increases in standing time with their eyes either open or closed by performing functional balance tests. Additionally, Valk and Michigan neuropathy screening scores significantly decreased after 10 sessions of IPC therapy. This study showed that IPC has a positive effect on diabetic neuropathy and balance.

Keywords

Diabetic neuropathy Instability Postural balance Intermittent pneumatic compression 

Notes

Acknowledgments

We would thank Dr. Soghrat Faghih Zadeh for his advice on statistical analysis and Dr. Manouchehr Khan Nakhjavani, Endocrinologist, for his cooperation in performing the study. This study was extracted from a Master of Science in Physical Therapy project and supported by Tarbiat Modares University, Tehran, Iran. The ethical committees of Tarbiat Modares University approved the study protocol and informed consent that each patient signed prior to his or her participation. Patients were all informed of the purposes of the study.

Conflicts of interest

None

References

  1. 1.
    Carrington AL, Abbott CA, Griffiths J, Jackson N, Johnson SR, Kulkarin J, et al. Peripheral vascular and nerve function associated with lower limb amputation in people with and without diabetes. Clin Sci. 2001;101:261–6.PubMedCrossRefGoogle Scholar
  2. 2.
    Edwards JL, Vincent AM, Cheng HT, Feldman EL. Diabetic neuropathy: mechanisms to management. Pharmacol Ther. 2008;120:1–34.PubMedPubMedCentralCrossRefGoogle Scholar
  3. 3.
    Jeffcoate WJ, Harding KG. Diabetic foot ulcers. Lancet. 2003;361:1545–51.PubMedCrossRefGoogle Scholar
  4. 4.
    Bonnet CT, Ray C. Peripheral neuropathy may not be the only fundamental reason explaining increased sway in diabetic individuals. Clin Biomech. 2011;26(7):699–706.CrossRefGoogle Scholar
  5. 5.
    Ajimsha M, Paul J, Chithra S. Efficacy of stability trainer in improving balance in type II diabetic patients with distal sensory neuropathy. J Diabetol. 2011;1(6):1–6.Google Scholar
  6. 6.
    Park SW. Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes. Diabetes Care. 2007;30:1507–12.PubMedCrossRefGoogle Scholar
  7. 7.
    Lord SR, Ward JA, Williams P, Anstey K. Physiological factors associated with falls in older community-dwelling women. J Am Geriatr Soc. 1994;42(10):1110–7.PubMedCrossRefGoogle Scholar
  8. 8.
    Simoneau GG, Ulbrecht JS, Derr JA, Becher MB, Cavanagh PR. Postural instability in patients with diabetic sensory neuropathy. Diabetes Care. 1994;17(12):1411–21.PubMedCrossRefGoogle Scholar
  9. 9.
    Tesfaye S. Neuropathy in diabetes. Medicine. 2006;34(3):91–4.CrossRefGoogle Scholar
  10. 10.
    Park SW, Goodpaster BH, Lee JS, Kuller LH, Boudreau R, Rekeneire ND, et al. Excessive loss of skeletal muscle mass in older adults with type 2 diabetes. Diabetes Care. 2009;32(11):1993–7.PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    Tesfaye S. Epidemiology and etiology of diabetic peripheral neuropathy. Adv Stud Med. 2004;4(10):1014–21.Google Scholar
  12. 12.
    Vinik AI, Strotmeyer ES, Nakave AA, Patel CV. Diabetic neuropathy in older adults. Clin Geriatr Med. 2008;24(3):1–19.CrossRefGoogle Scholar
  13. 13.
    Clanny WR. Apparatus for removing the pressure of the 60 cycles/min, they exhibited significant increased mosphere from the body or limbs. Lancet. 1835;1:804–5.CrossRefGoogle Scholar
  14. 14.
    Sinkowitz S, Gottlieb I. Throboangiitis obliterans –the con-. In a study of 80 male rats, vasodilation was maximal servative treatment by Bier’s hyperemia suction apparatus. JAMA. 1917;68:961–3.CrossRefGoogle Scholar
  15. 15.
    Delis KT, Azizi ZA, Stevens RJG, Wolf JHN, Nicolaides AN. Optimum intermittent pneumatic compression stimulus for lower limb venous emptying. Eur J Endovasc Surg. 2000;19:261–9.CrossRefGoogle Scholar
  16. 16.
    Mollsten A, Lajer M, Jorsal A, Tarnow L. The endothelial nitric oxide synthase gene and risk of diabetic nephropathy and development of cardiovscular disease in type 1 diabetes. Mol Genet Metab. 2009;97:80–4.PubMedCrossRefGoogle Scholar
  17. 17.
    Yamagishi SI, Matsui T. Nitric oxide, a janus-faced therapeutic target for diabetic microangiopathy—friends or foe? Pharmacol Res. 2011;64:187–94.PubMedCrossRefGoogle Scholar
  18. 18.
    Lee HJ, Delisa JA. Manual of nerve conduction study and surface anatomy for needle electromyography. Philadelphia: LIPPINCOTT WILLIAMS & WILKINS; 2005.Google Scholar
  19. 19.
    Meijer JWG, Sonoderen E, Blaauwwiekel E, Smit AJ, Groothoff JW, Eisma WH, et al. Diabetic neuropathy examination: a hierarchical scoring system to diagnose distal polyneuropathy in diabetes. Diabetes Care. 2000;23(6):750–3.PubMedCrossRefGoogle Scholar
  20. 20.
    Valk GD, Grootenhuis PA, Bouter LM, Bertelsmann FW. Complaints of neuropathy related to the clinical and neurophysiological assessment of nerve function in patients with diabetes mellitus. Diabetes Res Clin Pract. 1994;26:29–34.PubMedCrossRefGoogle Scholar
  21. 21.
    Moghtaderi A, Bakhshipour A, Rashidi H. Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy. Clin Neurol Neurosurg. 2006;108:477–81.PubMedCrossRefGoogle Scholar
  22. 22.
    Herman WH, Pop-Busui R, Braffett BH, Martin CL, Cleary PA, Albers JW, et al. Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications. Diabet Med. 2012;29(7):937–44.PubMedPubMedCentralCrossRefGoogle Scholar
  23. 23.
    Valk GD, Grootenhuis PA, Eijk JTM, Bouter LM, Bertelsmann FW. Methods for assessing diabetic polyneuropathy: validity and reproducibility of the measurement of sensory symptom severity and nerve function tests. Diabetes Res Clin Pract. 2000;47:87–95.PubMedCrossRefGoogle Scholar
  24. 24.
    Bohannon RW, Larkin PA, Cook AC, Gear J, Singer J. Decrease in timed balance test scores with aging. Phys Ther. 1984;64(7):1067–70.PubMedGoogle Scholar
  25. 25.
    Henderson WG, Tourteilotte WW, Potvin AR. Training examiners to administer a quantitative neurological examination for a multicenter clinical trial. Arch Phys Med Rehabil. 1975;56:289–95.PubMedGoogle Scholar
  26. 26.
    Salsabili H, Bahrpeyma F, Forogh B, Rajabali S. Dynamic stability training improves standing balance control in neuropathic patients with type 2 diabetes. J Rehabil Res Dev. 2011;48(7):775–86.PubMedCrossRefGoogle Scholar
  27. 27.
    Arnold BL, Schmitz RJ. Examination of balance measures produced by the Biodex stability system. J Athl Train. 1998;33(4):323–7.PubMedPubMedCentralGoogle Scholar
  28. 28.
    Rovan V, Stefanovskab A, Bernjakb A, Juvan K, Kocijancic A. Skin blood flow in the upper and lower extremities of diabetic patients with and without autonomic neuropathy. J Vasc Res. 2004;41:535–45.CrossRefGoogle Scholar
  29. 29.
    Rubanyi GM. The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol. 1993;22:S1–14.PubMedCrossRefGoogle Scholar
  30. 30.
    DeMeyer GR, Herman AG. Vascular endothelial dysfunction. Prog Cardiovasc Dis. 1997;39:325–42.CrossRefGoogle Scholar
  31. 31.
    Archer AG, Roberts VC, Watkins PJ. Blood flow patterns in painful diabetic neuropathy. Diabetologia. 1984;27:563–7.PubMedCrossRefGoogle Scholar
  32. 32.
    Quattriny C, Harris ND, Malik R, Tesfaye S. Impaired skin microvascular reactivity in painful diabetic neuropathy. Diabetes Care. 2007;30:655–9.CrossRefGoogle Scholar
  33. 33.
    Delis KT, Nicolaides AN. Effect of intermittent pneumatic compression of foot and calf on walking distance, hemodynamics, and quality of life in patients with arterial claudication. Ann Surg. 2005;241(3):431–41.PubMedPubMedCentralCrossRefGoogle Scholar
  34. 34.
    McBride RM, Mistretta CM. Light touch thresholds in diabetic patients. Diabetes Care. 1982;5(3):311–5.PubMedCrossRefGoogle Scholar
  35. 35.
    Lord SR, Menz HB, Tiedemann A. A physiological profile approach to falls risk assessment and prevention. Phys Ther. 2003;83:237–52.PubMedGoogle Scholar
  36. 36.
    Mettelinge TR, Calders P, Palmans T, Bossche LV, Noortgate NVD, Cambier D. Vibration perception threshold in relation to postural control and fall risk assessment in elderly. Disabil Rehabil. 2013;35(20):1712–7.PubMedCrossRefGoogle Scholar
  37. 37.
    Swenson RS. Review of clinical and functional neuroscience. Chapter 7. Hanover: Dartmouth Medical School; 2006.Google Scholar
  38. 38.
    Swenson RS. Review of clinical and functional neuroscience. Chapter 9. Hanover: Dartmouth Medical School; 2006.Google Scholar
  39. 39.
    Patton HD, Fuchs AF, Hille B, Scher AM, Steiner R (eds). Textbook of physiology. 21 ed. Philadelphia: W B Saunders Co; 1989.Google Scholar
  40. 40.
    Shumway-Cook A, Woollacott MH. Motor control: translating research into clinical practice. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2007.Google Scholar
  41. 41.
    Ahn S, Song R. Effects of Tai Chi exercise on glucose control, neuropathy scores, balance, and quality of life in patients with type 2 diabetes and neuropathy. J Altern Complement Med. 2011;18(12):1172–8.CrossRefGoogle Scholar
  42. 42.
    Richardson JK, Sandman D, Vela S. A focused exercise regimen improves clinical measures of balance in patients with peripheral neuropathy. Arch Phys Med Rehabil. 2001;82(2):205–9.PubMedCrossRefGoogle Scholar
  43. 43.
    Clarkson P, Montgomery HE, Mullen MJ, Donald AE, Powe AJ, Bull T, et al. Exercise training enhances endothelial function in young men. J Am Coll Cardiol. 1999;33(5):1379–85.PubMedCrossRefGoogle Scholar
  44. 44.
    Koller-Strametz JK, Matulla B, Wolzt M, Mtiller M, Entlicher J, Eichler HG, et al. Role of nitric oxide in exercise-induced vasodilation in man. Life Sci. 1998;62(11):1035–42.PubMedCrossRefGoogle Scholar
  45. 45.
    Tan X, Qi WN, Gu X, Urbaniak JR, Chen LE. Intermittent pneumatic compression regulates expression of nitric oxide synthases in skeletal muscles. J Biomech. 2006;39(13):2430–7.PubMedCrossRefGoogle Scholar
  46. 46.
    Chen LE, Liu K, Qi WN, Joneschild E, Tan X, Seaber AV, et al. Role of nitric oxide in vasodilation in upstream muscle during intermittent pneumatic compression. J Appl Physiol. 2002;92(2):559–66.PubMedCrossRefGoogle Scholar
  47. 47.
    Schmitz RJ, Arnold B. Intertester and intratester reliability of a dynamic balance protocol using the biodex stability system. J Sport Rehabil. 1998;7(2):95–101.Google Scholar

Copyright information

© Research Society for Study of Diabetes in India 2015

Authors and Affiliations

  • Shirin Salek
    • 1
  • Farid Bahrpeyma
    • 1
    • 2
  • Mohammad-Reza Mohajeri-Tehrani
    • 3
  1. 1.Deparment of Physical Therapy, Faculty of Medical SciencesTarbiat Modares UniversityTehranIran
  2. 2.Farid Bahrpeyma, Department of Physical Therapy, Faculty of Medical SciencesTarbiat Modares UniversityTehranIran
  3. 3.Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences InstituteTehran University of Medical SciencesTehranIran

Personalised recommendations